Fredrickson/WHO Classification of Hyperlipoproteinaemia
The concentration of four classes of serum lipoproteins can, when elevated, be regarded as pathological. These are:
- chylomicrons;
- VLDL;
- LDL; and
- beta-VLDL.
The hyperlipoproteinaemias can be classified according to which of the above is increased (see Table 1).
 |
| Table 1. WHO, World Health Organization;
LDL, low-density lipoprotein; VLDL, very-low-density lipoprotein;
IDL, intermediate-density lipoprotein. After [Durrington,
1995a] |
| Is the classification system useful? |
| The Fredrickson/World Health Organization (WHO)
classification sometimes causes confusion, largely because it may
be difficult to remember and is frequently wrongly regarded as a
diagnostic classification, when it is simply a way of reporting
which of the serum lipoproteins are elevated in a particular blood
sample. It is usually sufficient to remember that when cholesterol
alone is elevated there is a type IIa hyperlipoproteinaemia. When
both cholesterol and triglycerides are elevated the hyperlipoproteinaemia
is generally type IIb, but occasionally it is type V hyperlipoproteinaemia
(the serum will look milky if this is the case) and rarely, type
III. Type I hyperlipoproteinaemia is extraordinarily rare, and an
isolated increase in fasting serum triglycerides almost invariably
signifies type IV hyperlipoproteinaemia. |
| Should HDL-C be measured? |
| All hospital laboratories, in addition to measuring
cholesterol and triglyceride levels, should measure HDL-C in those
patients whose overall cardiovascular risk is being assessed critically,
usually because treatment of their hyperlipoproteinaemia with drugs
is under consideration. In women particularly, an elevated cholesterol
level may result from a relatively high HDL-C concentration and
may not signify any increased risk of CHD. High serum HDL-C does
not have a Fredrickson/WHO class, and as evidence suggests it is
associated with longevity, it cannot be regarded as an atherogenic
hyperlipoproteinaemia. Conversely, low HDL-C is associated with
an increased cardiovascular risk, particularly if total serum cholesterol
and triglycerides are also elevated or other risk factors are present.
|
|